Oxidative stress and persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide and different oxygen concentrations

Objectives: The aim of this study was to determine the effects of inhaled NO with different oxygen concentrations on the inflammatory cascade in newborns with hypoxic respiratory failure secondary to persistent pulmonary hypertension. Methods: 60 newborns received iNO and 30 of them received an initial oxygen concentration of 45% (group 1), while the other 30 newborns received an initial oxygen concentration of 80% (group 2). The levels of inflammatory cytokines (IL-6, IL-8, TNF-α) were measured. The clinical outcome was also recorded. Results: The findings show that interleukin concentrations (IL-6, IL-8, TNF-α) were significantly decreased between 0 and 72 hours (p < 0.01) in the newborns exposed to initial oxygen concentration of 45% and significantly increased in the other group. Conclusions: When inhaled, NO was co-administered with concentration of O2 <45%, anti-inflammatory responses occurred, in accord with evidence in the published literature. The benefits of iNO on the clinical outcome in the current study demonstrate that inhaled NO in both groups was associated with improved short-term oxygenation.

[1]  A. Gow,et al.  Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants , 2008, Pediatrics.

[2]  J. Russell,et al.  Pulmonary Hemodynamics in Neonatal Lambs Resuscitated with 21%, 50%, and 100% Oxygen , 2007, Pediatric Research.

[3]  R. Savani,et al.  Inflammatory Markers and Mediators in Tracheal Fluid of Premature Infants Treated With Inhaled Nitric Oxide , 2007, Pediatrics.

[4]  S. Wedgwood,et al.  Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[5]  S. Wedgwood,et al.  Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[6]  E. Chi,et al.  Augmented lung injury due to interaction between hyperoxia and mechanical ventilation* , 2004, Critical care medicine.

[7]  S. Wedgwood,et al.  Increased Superoxide Generation Is Associated With Pulmonary Hypertension in Fetal Lambs: A Role for NADPH Oxidase , 2003, Circulation research.

[8]  G. Nussdorfer,et al.  Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. , 2001, International review of cytology.

[9]  J. Tyson,et al.  Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes , 2000, Pediatrics.

[10]  J. Estrela,et al.  Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. , 1999, Pharmacological research.

[11]  J. Fortenberry,et al.  Effects of exogenous nitric oxide and hyperoxia on lung fibroblast viability and DNA fragmentation. , 1999, Biochemical and biophysical research communications.

[12]  J. A. Garrote,et al.  Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. , 1999, Allergologia et immunopathologia.

[13]  J. Kattwinkel,et al.  Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study , 1998, Pediatrics.

[14]  J. Kattwinkel,et al.  Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. , 1998, Pediatrics.

[15]  A. Stark,et al.  Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. , 1997, Pediatrics.

[16]  S. Erzurum,et al.  Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. , 1997, American journal of respiratory cell and molecular biology.

[17]  G. Redding,et al.  Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn , 1997 .

[18]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .

[19]  R. Polin,et al.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. , 1997, The New England journal of medicine.

[20]  A. Halbower,et al.  Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease , 1997, Pediatric Research.

[21]  D. Payen,et al.  Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. , 1996, American journal of respiratory and critical care medicine.

[22]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[23]  E. Shaffer,et al.  Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[24]  L. Foubert,et al.  Safety guidelines for use of nitric oxide , 1992, The Lancet.

[25]  E. Shaffer,et al.  Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. , 1992, Lancet.

[26]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.